Endpoints News – Biotech and pharma business news, with a focus …
Endpoints News provides up-to-date biotech, drug, pharma, and health news for business and professional readers.
News – Endpoints News
reset password. We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours. email
Endpoints at #BIO23: The dawn of a new biotech era
The dawn of a new biotech era. The biotech industry’s annual trade conference is back in Boston. We assess where we are as an industry and break down the future trends in biopharma.
Endpoints at #JPM22 - A look at what's to come in 2022
A look at what's to come in 2022 Jan 10 through Jan 12 virtual event. The biopharma world kicks off each year with a frenzy of activity at JP Morgan. Endpoints has been there to chronicle it with wall-to-wall coverage, and our founder and editor John Carroll has convened top newsmakers to provide detailed insights about their strategies.
Subscribe - Endpoints News
Essential biopharma news and analysis Independent journalism since 2016. Our mission is to deliver the best news product in biopharma and become an essential read for industry leaders across the ...
About Endpoints News – Endpoints News
John D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 20 years.
It’s mission critical this time as biotech looks to bounce back
It’s mission critical this time as biotech looks to bounce back 9-11 January 2023, San Francisco. We’ve gone quite a stretch without a live JP Morgan conference.
Big dreams dominate among next-gen biotech players
Sep 22, 2024 · Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a biotech. Here’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or …
ESMO23 | Cancer breakthroughs and barriers in oncology R&D
Endpoints is on the ground at ESMO this year and the lineup will be one to watch — what drugs in the cancer pipeline show promise? Which ones won’t make it past the goal line? Join us as we break down the highlights and readouts with our expert roundtable moderated by Endpoints journalists and more. Tune in online as our team reports from …
Endpoints Careers - Find your next biopharma job
New benefit for Enterprise subscribers. All companies with an Enterprise subscription to Endpoints News will now receive two spotlight job postings per year at no charge.Contact your company subscriptions manager or DeAna ([email protected]) for more information.. For sales inquires or package requests, connect with Meg at [email protected].